Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first‐line setting
暂无分享，去创建一个
N. Conev | I. Donev | M. Radanova | R. Staneva | E. Dimitrova | J. Arabadjiev | M. Eneva | M. Taushanova-Hadjieva | R. Gencheva | M. Petrova | P. Kraleva | S. Hadjidekova | D. Stoyanov | E. Tazimova | S. Bachurska | M. Tsvetkova | G. Zhbantov | T. Karanikolova | D. Manov | A. Ivanova